Reserpine (versus unexposed) updated on 03-11-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Neural Tube Defects6.30 [0.71, 55.64]-1 study1,2026not evaluable ROB-

Hide endpoints reported in only one study ...